US6174330B1
Expired / Lapsed
US
⏱️ 0.0 years remaining
Bioabsorbable marker having radiopaque constituents
Assignee: Boston Scientific Scimed Inc
•
Filing: 1997-08-01
•
Granted: 2001-01-16
•
Expires: 2017-08-01
Abstract
Abstract A temporary bioabsorbable-radiopaque marker for use on an implantable endoprosthesis. The bioabsorbable-radiopaque marker is adapted to be disposed on or adjacent an implantable endoprosthesis in a body lumen for a predetermined amount of time until the bioabsorbable and radiopaque materials are absorbed or dispersed in the body. The bioabsorbable material may include polylactide and the radiopaque material may include bismuth trioxide and barium sulfate. The weight percent of the radiopaque material in the bioabsorbable material may range from about 1% to about 80%. The radiopaque material may have a linear attenuation coefficient of from about 10 cm-1 at 50 KeV to about 120 cm-1 at 50 KeV.
Inventors
- 👤 Jonathan S. Stinson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 14:59
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/82; A61F2/86; A61F2/90; A61B; A61B17/00; A61B17/12; A61B17/12022; A61B17/12099; A61B17/12109; A61B17/12131; A61B17/1214; A61B17/12168; A61B17/12172; A61B90/00; A61B90/39; A61L; A61L27/00; A61L27/50; A61L27/58; A61L31/00; A61L31/14; A61L31/148; A61L31/18; A61F2/02; A61F2/30; A61F2002/30001; A61F2002/30003; A61F2002/3006; A61F2002/30062; A61F2002/3008; A61F2210/00; A61F2210/0004; A61F2250/00; A61F2250/0058; A61F2250/0096; A61F2250/0098; A61M; A61M25/00; A61M25/01; A61M25/0105; A61M25/0108
Claims Analysis
Total Claims: 21
Claim 1
Independent Claim
116 words
An endoprosthesis and radiopaque marker assembly comprising: an expandable endoprosthesis made of a substantially radiolucent material; and at least one elongated radiopaque marker at least partially functionally cooperative together with the expandable endoprosthesis, the at least one elongated radiopaque marker comprising bioabsorbable material and radiopaque material and having a proximal end, a distal end, and a thickness, the radiopaque material including metallic particles of a size less than about 10 microns and having a linear attenuation coefficient ranging from about 5.46 cm −1 at 50 KeV to about 149.08 cm −1 at 50 KeV, the weight percentage of the metallic particles in the at least one elongated radiopaque marker ranging from about 1% to about 80%.
Claim 2
Dependent Claim
116 words
An endoprosthesis and radiopaque marker assembly comprising: an expandable endoprosthesis made of a substantially radiolucent material; and at least one elongated radiopaque marker at least partially functionally cooperative together with the expandable endoprosthesis, the at least one elongated radiopaque marker comprising bioabsorbable material and radiopaque material and having a proximal end, a distal end, and a thickness, the radiopaque material including metallic particles of a size less than about 10 microns and having a linear attenuation coefficient ranging from about 5.46 cm −1 at 50 KeV to about 149.08 cm −1 at 50 KeV, the weight percentage of the metallic particles in the at least one elongated radiopaque marker ranging from about 1% to about 80%.
Claim 3
Dependent Claim
37 words
The endoprosthesis and radiopaque marker assembly of claim 1 wherein the expandable endoprosthesis further includes a plurality of elongated filaments and wherein the at least one elongated radiopaque marker is disposed between at least two elongated filaments.
Claim 4
Dependent Claim
36 words
The endoprosthesis and radiopaque marker assembly of claim 2 wherein the at least one elongated radiopaque marker and one or more of the plurality of elongated filaments are at least partially braided to form a structure.
Claim 5
Dependent Claim
17 words
The endoprosthesis and radiopaque marker assembly of claim 2 wherein the plurality of elongated filaments are bioabsorbable.
Claim 6
Dependent Claim
20 words
The endoprosthesis and radiopaque marker assembly of claim 2 wherein the plurality of elongated filaments include a polymer or copolymer.
Claim 7
Dependent Claim
39 words
The endoprosthesis and radiopaque marker assembly of claim 1 wherein the bioabsorbable material includes at least one of poly-L-lactide, poly-D-lactide, polyglycolide, polydioxanone, polycaprolactone, polygluconate, polylactic acid-polyethylene oxide copolymers, modified cellulose, collagen, poly(hydroxybutyrate), polyanhydride, polyphosphoester, poly(amino acids), and combinations thereof.
Claim 8
Dependent Claim
30 words
The endoprosthesis and radiopaque marker assembly of claim 1 wherein the at least one elongated radiopaque marker has an average thickness of from about 20 microns to about 500 microns.
Claim 9
Dependent Claim
26 words
The endoprosthesis and radiopaque marker assembly of claim 1 wherein the radiopaque material includes at least one of tantalum, bismuth, iridium, platinum, gold and combinations thereof.
Claim 10
Dependent Claim
25 words
The endoprosthesis and radiopaque marker assembly of claim 1 wherein one of the bioabsorbable material or radiopaque material is coated or compounded with the other.
Claim 11
Dependent Claim
25 words
The endoprosthesis and radiopaque marker assembly of claim 1 wherein the at least one elongated radiopaque marker substantially degrades in less than about 3 years.
Claim 12
Dependent Claim
35 words
The endoprosthesis and radiopaque marker assembly of claim 1 wherein the at least one elongated radiopaque marker includes at least one of a hollow, cavity, and porous portion and the radiopaque material is disposed therein.
Claim 13
Dependent Claim
31 words
The endoprosthesis and radiopaque marker assembly of claim 1 wherein the at least one elongated radiopaque marker has radiopacity for at least one week after being disposed in the body lumen.
Claim 14
Dependent Claim
16 words
The endoprosthesis and radiopaque marker assembly of claim 2 wherein the endoprosthesis has a tubular structure.
Claim 15
Dependent Claim
24 words
The endoprosthesis and radiopaque marker assembly of claim 1 wherein the weight percentage of the metallic particles ranges from about 15% to about 60%.
Claim 16
Dependent Claim
122 words
An endoprosthesis and radiopaque marker assembly comprising: An expandable endoprosthesis made of an at least partially radiolucent material and including a plurality of elongated filaments; and at least one elongated radiopaque marker disposed between at least two of the elongated filaments at least partially functionally cooperative together with the endoprosthesis, the at least one elongated radiopaque marker comprising bioabsorbable material and radiopaque material and having a proximal end, a distal end, and a thickness, the radiopaque material having a linear attenuation coefficient ranging from about 5.46 cm −1 at 50 KeV to about 151.53 cm −1 at 50 KeV and a weight percentage of the radiopaque material in the at least one elongated radiopaque marker ranging from about 1% to about 80%.
Claim 17
Dependent Claim
122 words
An endoprosthesis and radiopaque marker assembly comprising: An expandable endoprosthesis made of an at least partially radiolucent material and including a plurality of elongated filaments; and at least one elongated radiopaque marker disposed between at least two of the elongated filaments at least partially functionally cooperative together with the endoprosthesis, the at least one elongated radiopaque marker comprising bioabsorbable material and radiopaque material and having a proximal end, a distal end, and a thickness, the radiopaque material having a linear attenuation coefficient ranging from about 5.46 cm −1 at 50 KeV to about 151.53 cm −1 at 50 KeV and a weight percentage of the radiopaque material in the at least one elongated radiopaque marker ranging from about 1% to about 80%.
Claim 18
Dependent Claim
36 words
The endoprosthesis and radiopaque marker assembly of claim 15 wherein the at least one elongated radiopaque marker and one or more of the plurality of elongated filaments are at least partially braided to form a structure.
Claim 19
Dependent Claim
17 words
The endoprosthesis and radiopaque marker assembly of claim 15 wherein the plurality of elongated filaments are bioabsorbable.
Claim 20
Dependent Claim
33 words
The endoprosthesis and radiopaque marker assembly of claim 17 wherein the bioabsorbable material is metabolized through or excreted from the body and the radiopaque material is excreted from or stored in the body.
Claim 21
Dependent Claim
34 words
The endoprosthesis and radiopaque marker assembly of claim 15 wherein the radiopaque material has a linear attenuation coefficient ranging from about 5.46 cm −1 at 50 KeV to about 149.08 −1 at 50 KeV.
References Cited (Backward Citations)
US4202349A
Cited
US4447239A
Cited
WO1980002641A1
Cited
US4475972A
Cited
EP0183372A1
Cited
US4787391A
Cited
US4738740A
Cited
US4681110A
Cited
US4693237A
Cited
US5061275A
Cited
US4722344A
Cited
US5024232A
Cited
US4968317B1
Cited
US4968317A
Cited
US5047050A
Cited
US5059211A
Cited
US5527337A
Cited
US5306286A
Cited
WO1990001969A1
Cited
US5085629A
Cited
WO1990004982A1
Cited
US5026377A
Cited
US5133660A
Cited
US5015183A
Cited
WO1991010766A1
Cited
US5545208A
Cited
US5725567A
Cited
US5133742A
Cited
US5229431A
Cited
US5478352A
Cited
US5160341A
Cited
US5116360A
Cited
US5163951A
Cited
US5354257A
Cited
US5674286A
Cited
WO1992016166A1
Cited
US5697969A
Cited
US5256158A
Cited
US5591172A
Cited
US5527354A
Cited
US5551954A
Cited
US5500013A
Cited
US5464450A
Cited
US5591222A
Cited
US5441517A
Cited
US5203777A
Cited
US5591224A
Cited
US5201757A
Cited
US5645559A
Cited
US5366504A
Cited
US5177170A
Cited
US5762625A
Cited
WO1994006373A1
Cited
WO1994006372A1
Cited
US5484444A
Cited
US5653747A
Cited
US5419760A
Cited
US5346981A
Cited
US5423849A
Cited
US5630840A
Cited
US5628787A
Cited
US5415546A
Cited
US5405402A
Cited
US5464650A
Cited
US5624411A
Cited
US5320602A
Cited
US5700285A
Cited
US5498227A
Cited
US5429617A
Cited
US5609627A
Cited
US5556413A
Cited
US5725572A
Cited
EP0679372A2
Cited
EP0689807A2
Cited
US5433727A
Cited
WO1996005872A1
Cited
EP0709068A2
Cited
US5674277A
Cited
US5591226A
Cited
US5628755A
Cited
US5683449A
Cited
US5662703A
Cited
WO1996040000A1
Cited
WO1997011724A1
Cited
US5725517A
Cited
US5628788A
Cited
EP0775472A2
Cited
US5843158A
Cited
US5824042A
Cited
US5670161A
Cited
US5676146A
Cited
US5676146B1
Cited
WO1998018408A1
Cited
US5741327A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2004-01-16 | 2004-07-17 | 2005-01-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2008-01-16 | 2008-07-17 | 2009-01-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2012-01-16 | 2012-07-17 | 2013-01-16 | $7700.00 | Window Closed / Lapsed |